זובירקס טבליות 200 מג इसराइल - हिब्रू - Ministry of Health

זובירקס טבליות 200 מג

glaxo smith kline (israel) ltd - aciclovir - טבליה - aciclovir 200 mg - aciclovir - aciclovir - for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. for the prophylaxis of herpes simplex infections in immune-compromised patients. for the treatment of herpes zoster infections . for the treatment of chickenpox.

זובירקס טבליות מסיסות 800 מג इसराइल - हिब्रू - Ministry of Health

זובירקס טבליות מסיסות 800 מג

glaxo smith kline (israel) ltd - aciclovir - טבליות ניתנות לפיזור - aciclovir 800 mg - aciclovir - aciclovir - for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. for the prophylaxis of herpes simplex infections in immune-compromised patients. for the treatment of herpes zoster infections . for the treatment of chickenpox in the following groups: 1. non-pregnant patients over 13 years-of-age who are otherwise healthy. 2. children over 12 months of age with a chronic cutaneous or pulmonary condition, or receiving long-term salicylate therapy. 3. children receiving short or intermittent courses of aerosolized corticosteroids.

אלוקום קרם इसराइल - हिब्रू - Ministry of Health

אלוקום קרם

organon pharma israel ltd., israel - mometasone furoate - קרם - mometasone furoate 0.1 % - mometasone - mometasone - for the relief of the inflammatory and pruritic manifestation of corticisteroid responsive dermatoses

אלוקום משחה इसराइल - हिब्रू - Ministry of Health

אלוקום משחה

organon pharma israel ltd., israel - mometasone furoate - משחה - mometasone furoate 0.1 % - mometasone - mometasone - for the relief of the inflammatory and pruritic manifestation of corticisteroid responsive dermatoses.

פרוברה 5 מג इसराइल - हिब्रू - Ministry of Health

פרוברה 5 מג

pfizer pfe pharmaceuticals israel ltd - medroxyprogesterone acetate - טבליה - medroxyprogesterone acetate 5 mg - medroxyprogesterone - medroxyprogesterone - in cases requiring progesterone supplement.

טוביאז 4 מג इसराइल - हिब्रू - Ministry of Health

טוביאז 4 מג

pfizer pharmaceuticals israel ltd - fesoterodine fumarate - טבליות עם שחרור מושהה - fesoterodine fumarate 4 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.

טוביאז 8 מג इसराइल - हिब्रू - Ministry of Health

טוביאז 8 מג

pfizer pharmaceuticals israel ltd - fesoterodine fumarate - טבליות עם שחרור מושהה - fesoterodine fumarate 8 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.

טרזוסין טבע    5 מג इसराइल - हिब्रू - Ministry of Health

טרזוסין טבע 5 מג

teva pharmaceutical industries ltd, israel - terazosin as hydrochloride dihydrate - טבליה - terazosin as hydrochloride dihydrate 5 mg - terazosin - terazosin - for symptomatic treatment of urinary obstructon caused by benign prostatic hyperplasia (bph). for mild to moderate hypertension.

טרזוסין טבע    2 מג इसराइल - हिब्रू - Ministry of Health

טרזוסין טבע 2 מג

teva pharmaceutical industries ltd, israel - terazosin as hydrochloride dihydrate - טבליה - terazosin as hydrochloride dihydrate 2 mg - terazosin - terazosin - for symptomatic treatment of urinary obstructon caused by benign prostatic hyperplasia (bph). for mild to moderate hypertension.

טובי פודהלר 28 מג इसराइल - हिब्रू - Ministry of Health

טובי פודהלר 28 מג

dexcel ltd, israel - tobramycin - אבקה לשאיפה בקפסולות קשיחות - tobramycin 28 mg - tobramycin - tobramycin - suppressive therapy of chronic pulmonary infection due to pseudomonas aeruginosa in adults and children aged 6 years and older with cystic fibrosis.